Chronic Cough is the fastest way to get to the money IF the data pans out to be effective in humans. Just look at the timeline of Bellus Health. It's all there for a real world assessment. Phase 2b inside of 9 months. It's right here in black and white:
There's zero need to guess at what timeline can be accomplished during the pandemic for Chronic Cough. Simply follow that path. If so, the CEO can then claim to be in comparison to Bellus Health. There's also enough information out there to know what bar Algernon needs to clear in order to surpass all others in the Chronic Cough space. My belief is showing a 33% reduction in cough with zero negative taste will top all contenders for first in class treatment.
It's a layman's assessment that I'm interested in knowing what "the brain guy" believes needs to be accomplished for first in class.
A standalone Chronic Cough clinical trial powered for stat sig is the best chance at substantially increasing market value as witnessed by Bellus Health's initial run to a US Billion dollar valuation and headed back to that valuation pending their data readout in Q4 2020.
News 
Market Data 
Discover 
